Lauri Kareinen

876 total citations
24 papers, 390 citations indexed

About

Lauri Kareinen is a scholar working on Infectious Diseases, Molecular Biology and Neurology. According to data from OpenAlex, Lauri Kareinen has authored 24 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 4 papers in Molecular Biology and 4 papers in Neurology. Recurrent topics in Lauri Kareinen's work include SARS-CoV-2 and COVID-19 Research (11 papers), Viral Infections and Vectors (8 papers) and COVID-19 Clinical Research Studies (6 papers). Lauri Kareinen is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (11 papers), Viral Infections and Vectors (8 papers) and COVID-19 Clinical Research Studies (6 papers). Lauri Kareinen collaborates with scholars based in Finland, Switzerland and United Kingdom. Lauri Kareinen's co-authors include Olli Vapalahti, Tarja Sironen, Jussi Hepojoki, Teemu Smura, Lev Levanov, Anne J. Jääskeläinen, Suvi Kuivanen, Hannes Lohi, Katriina Tiira and Jenni Virtanen and has published in prestigious journals such as Nature, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Lauri Kareinen

22 papers receiving 379 citations

Peers

Lauri Kareinen

PHEOH

PARAS

GENET

Rachel M. Maison United States

Sebastian E. Carrasco United States

Todd M. Bell United States

Léa Lucıanı France

Azza Abdelgawad Germany

Peter van Run Netherlands

Ana Lisa do Vale Gomes Brazil

Alexandre Servat France

Fanghui Hou China

Willy W. Suen Australia

Rachel M. Maison United States

Lauri Kareinen

545 ×2.1

58 ×0.8

PHEOH

17 ×0.3

PARAS

61 ×1.2

GENET

62 ×1.3

Citations per year, relative to Lauri Kareinen Lauri Kareinen (= 1×) peers Rachel M. Maison

Countries citing papers authored by Lauri Kareinen

Since Specialization

Citations

This map shows the geographic impact of Lauri Kareinen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lauri Kareinen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lauri Kareinen more than expected).

Fields of papers citing papers by Lauri Kareinen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lauri Kareinen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lauri Kareinen. The network helps show where Lauri Kareinen may publish in the future.

Co-authorship network of co-authors of Lauri Kareinen

This figure shows the co-authorship network connecting the top 25 collaborators of Lauri Kareinen. A scholar is included among the top collaborators of Lauri Kareinen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lauri Kareinen. Lauri Kareinen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Airas, Niina, Su Duy Nguyen, Matti Jauhiainen, et al.. (2025). Heterozygous Korat cats with LDL receptor mutation are asymptomatic and normolipidemic. Research in Veterinary Science. 193. 105784–105784. 1 indexed citations

Kuivanen, Suvi, Ravi Kant, Lauri Kareinen, et al.. (2024). Nanobody engineering for SARS-CoV-2 neutralization and detection. Microbiology Spectrum. 12(4). e0419922–e0419922. 4 indexed citations

Kareinen, Lauri, Ruut Uusitalo, Essi M. Korhonen, et al.. (2024). Stable Levels of Antibodies Against Unrelated Toxoid Vaccines After COVID-19: COVID-19 Infection Does Not Affect Toxoid Vaccine Antibody Levels. SHILAP Revista de lepidopterología. 8(2). 74–87.

Kang, Yilin, Jussi Hepojoki, Takayuki Mito, et al.. (2024). Ancestral allele of DNA polymerase gamma modifies antiviral tolerance. Nature. 628(8009). 844–853. 11 indexed citations

Kant, Ravi, Lauri Kareinen, Tarja Sironen, et al.. (2024). The assembly of neutrophil inflammasomes during COVID-19 is mediated by type I interferons. PLoS Pathogens. 20(8). e1012368–e1012368. 3 indexed citations

Alzahrani, Othman R., Abdullah D. Alanazi, Lauri Kareinen, et al.. (2022). Clinical and Serological Findings of COVID-19 Participants in the Region of Makkah, Saudi Arabia. Diagnostics. 12(7). 1725–1725. 1 indexed citations

Mosselhy, Dina A., Lauri Kareinen, Jenni Virtanen, et al.. (2022). Inhibition of SARS-CoV-2 Alpha Variant and Murine Noroviruses on Copper-Silver Nanocomposite Surfaces. Nanomaterials. 12(7). 1037–1037. 5 indexed citations

Hepojoki, Jussi, Satu Hepojoki, Carla Bellomo, et al.. (2021). Hantavirus infection-induced B cell activation elevates free light chains levels in circulation. PLoS Pathogens. 17(8). e1009843–e1009843. 7 indexed citations

Kant, Ravi, Lauri Kareinen, Teemu Smura, et al.. (2021). Common Laboratory Mice Are Susceptible to Infection with the SARS-CoV-2 Beta Variant. Viruses. 13(11). 2263–2263. 19 indexed citations

10.

Kareinen, Lauri, Leonóra Szirovicza, Lev Levanov, et al.. (2021). A Generic, Scalable, and Rapid Time-Resolved Förster Resonance Energy Transfer-Based Assay for Antigen Detection—SARS-CoV-2 as a Proof of Concept. mBio. 12(3). 29 indexed citations

11.

Kareinen, Lauri, Lev Levanov, Sointu Mero, et al.. (2021). A 10-Minute “Mix and Read” Antibody Assay for SARS-CoV-2. Viruses. 13(2). 143–143. 17 indexed citations

12.

Kareinen, Lauri, et al.. (2021). Carboxypeptidase A3 expression in canine mast cell tumors and tissue-resident mast cells. Veterinary Pathology. 59(2). 236–243. 4 indexed citations

13.

Haljasmägi, Liis, Pauliina Rumm, Anu Remm, et al.. (2020). Longitudinal proteomic profiling reveals increased early inflammation and sustained apoptosis proteins in severe COVID-19. Scientific Reports. 10(1). 20533–20533. 59 indexed citations

14.

Kantele, Anu, Tinja Lääveri, Lauri Kareinen, et al.. (2020). SARS-CoV-2 infections among healthcare workers at Helsinki University Hospital, Finland, spring 2020: Serosurvey, symptoms and risk factors. Travel Medicine and Infectious Disease. 39. 101949–101949. 30 indexed citations

15.

Kareinen, Lauri, Joseph Ogola, Teemu Smura, et al.. (2020). Range Expansion of Bombali Virus in Mops condylurus Bats, Kenya, 2019. Emerging infectious diseases. 26(12). 3007–3010. 18 indexed citations

16.

Kareinen, Lauri, Satu Hepojoki, Eili Huhtamo, et al.. (2019). Immunoassay for serodiagnosis of Zika virus infection based on time-resolved Förster resonance energy transfer. PLoS ONE. 14(7). e0219474–e0219474. 8 indexed citations

17.

Hepojoki, Satu, Lauri Kareinen, Tomas Strandin, et al.. (2019). Urine and Free Immunoglobulin Light Chains as Analytes for Serodiagnosis of Hantavirus Infection. Viruses. 11(9). 809–809. 5 indexed citations

18.

Smura, Teemu, Elina Tonteri, Anu Jääskeläinen, et al.. (2019). Recent establishment of tick-borne encephalitis foci with distinct viral lineages in the Helsinki area, Finland. Emerging Microbes & Infections. 8(1). 675–683. 26 indexed citations

19.

Kuivanen, Suvi, Lev Levanov, Lauri Kareinen, et al.. (2019). Detection of novel tick-borne pathogen, Alongshan virus, in Ixodes ricinus ticks, south-eastern Finland, 2019. Eurosurveillance. 24(27). 62 indexed citations

20.

Tiira, Katriina, Lauri Kareinen, Anne Thomas, et al.. (2012). Environmental Effects on Compulsive Tail Chasing in Dogs. PLoS ONE. 7(7). e41684–e41684. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact